Prolactin regulatory element-binding (PREB) protein regulates hepatic glucose homeostasis

Prolactin regulatory element-binding (PREB) protein is a transcription factor that regulates prolactin (PRL) gene expression. PRL, also known as luteotropic hormone or luteotropin, is well known for its role in producing milk. However, the role of PREB, in terms of hepatic glucose metabolism, is not...

Full description

Saved in:
Bibliographic Details
Published inBiochimica et biophysica acta. Molecular basis of disease Vol. 1864; no. 6; pp. 2097 - 2107
Main Authors Park, Joo-Man, Kim, Mi-Young, Kim, Tae-Hyun, Min, Dong-Kook, Yang, Ga Eul, Ahn, Yong-Ho
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 01.06.2018
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Prolactin regulatory element-binding (PREB) protein is a transcription factor that regulates prolactin (PRL) gene expression. PRL, also known as luteotropic hormone or luteotropin, is well known for its role in producing milk. However, the role of PREB, in terms of hepatic glucose metabolism, is not well elucidated. Here, we observed expression of Preb in the mouse liver, in connection with glucose homeostasis. Morevoer, Preb was downregulated in db/db, ob/ob and high-fat diet-induced obese (DIO) mice, concurrent with upregulation of the liver genes glucose-6-phosphatase (G6pc) and phosphoenolpyruvate carboxykinase-1 (Pck). Administration of adenovirus-Preb (Ad-Preb) to db/db, ob/ob, and DIO mice diminished glucose, insulin, and pyruvate tolerance, which analogously, were impaired in normal (C57BL/6) mice knocked down for Preb, via infection with Ad-shPreb (anti-Preb RNA), indicating Preb to be a negative regulator of liver gluconeogenic genes. We further demonstrate that Preb negatively influences gluconeogenic gene expression, by directly binding to their promoters at a prolactin core-binding element (PCBE). A better understanding of Preb gene expression, during the pathogenesis of hepatic insulin resistance, could ultimately provide new avenues for therapies for metabolic syndrome, obesity, and type-2 diabetes mellitus, disorders whose worldwide incidences are increasing drastically. •PREB expression is decreased in fasting states and insulin-resistant diabetic model mice.•Glucose homeostasis is improved by Ad-Preb administration in diabetic model mice.•PREB directly binds to PCBE on promoter of gluconeogenic genes.•The protein levels of PREB is regulated by hormones (cAMP and insulin).
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0925-4439
1879-260X
DOI:10.1016/j.bbadis.2018.03.024